financetom
Business
financetom
/
Business
/
Verizon owes $175 million in patent infringement case, Texas jury says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Verizon owes $175 million in patent infringement case, Texas jury says
Jul 23, 2025 6:37 PM

(Reuters) -A federal court in Marshall, Texas, said on Wednesday that U.S. telecom company Verizon Wireless must pay $175 million in damages for violating an inventor's patent rights related to wireless communications technology.

The jury's decision in favor of Headwater Research comes just months after the firm secured a $278 million verdict in a separate patent dispute against Samsung over wireless technology, also in the same Marshall, Texas, federal court.

Spokespeople for Verizon and attorneys for Headwater did not immediately respond to requests for comment on Wednesday's verdict.

Tyler, Texas-based Headwater was founded by scientist and inventor Gregory Raleigh. Headwater said in its complaint in 2023 that its patented technology allows wireless devices to "reduce data usage and network congestion, extend battery life by decreasing power consumption, and enable users to stay connected."

Headwater said it shared information about its technology with Verizon under a non-disclosure agreement between 2009 and 2011. The complaint said that Verizon's mobile phones, tablets and cellular networks infringed Headwater's patents.

Verizon denied the allegations and argued that the patents were invalid.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Aecon Acquiring United Engineers & Constructors to Boost North American Nuclear Capability
Aecon Acquiring United Engineers & Constructors to Boost North American Nuclear Capability
Nov 3, 2024
08:18 AM EDT, 10/28/2024 (MT Newswires) -- Aecon Group ( AEGXF ) on Monday said that it has entered into a definitive purchase agreement to acquire United Engineers & Constructors, a nuclear and conventional power contractor headquartered in Mount Laurel, New Jersey, from affiliates of CriticalPoint Capital, for US$33 million in cash. United's management and operational teams will join Aecon...
Johnson & Johnson Says Phase 3 Trial of Crohn's Disease Treatment Showed High Remission Rates
Johnson & Johnson Says Phase 3 Trial of Crohn's Disease Treatment Showed High Remission Rates
Nov 3, 2024
08:19 AM EDT, 10/28/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday that results from a phase 3 study of Tremfya as a treatment for Crohn's disease showed high remission rates among tested patients. The first 12 weeks of the trial where Tremfya was administered subcutaneously showed that 56.1% of treated patients achieved clinical remission, J&J said....
Atlas Lithium Receives Approval for Brazil Lithium Mining, Processing Operations
Atlas Lithium Receives Approval for Brazil Lithium Mining, Processing Operations
Nov 3, 2024
08:19 AM EDT, 10/28/2024 (MT Newswires) -- Atlas Lithium ( ATLX ) said Monday it has received an operational permit from the Brazilian state of Minas Gerais for the Neves lithium-mining project. With the approval, Atlas has the necessary permits to assemble and operate a lithium processing plant and pursue open-pit mining at one of its deposits. The approval, which...
AbbVie to buy Alzheimer's therapy developer Aliada Therapeutics for $1.4 bln
AbbVie to buy Alzheimer's therapy developer Aliada Therapeutics for $1.4 bln
Nov 3, 2024
Oct 28 (Reuters) - U.S. drugmaker AbbVie ( ABBV ) said on Monday it would acquire Aliada Therapeutics for $1.4 billion in cash, gaining access to the therapy developer's Alzheimer's disease drug candidate. Aliada is developing ALIA-1758, an antibody for the Alzheimer's disease, which AbbVie ( ABBV ) said could be a potential best-in-class therapy. The deal is expected to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved